Sienna Biopharmaceuticals, Inc. (SNNA) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 72 transactions totaling $19.5M, demonstrating a bullish sentiment with $16.1M in net insider flow. The most recent transaction on Oct 2, 2019 involved a transaction of 2,396 shares valued at $551.
No significant insider buying has been recorded for SNNA in the recent period.
No significant insider selling has been recorded for SNNA in the recent period.
Based on recent SEC filings, insider sentiment for SNNA is bullish with an Insider Alignment Score of 91/100 and a net flow of $16.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Sienna Biopharmaceuticals, Inc. (SNNA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading SNNA stock, having executed 72 transactions in the past 90 days. The most active insider is Kristina Burow (Executive), who has made 7 transactions totaling $5.4M.
Get notified when executives and directors at SNNA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 2, 2019 | Azoy Alexander | Executive | Payment | 2,396 | $0.23 | $551 | |
| Aug 6, 2019 | Frederick Beddingfield III | Executive | Award | 150,000 | $N/A | $0 | |
| Aug 6, 2019 | F. Lizzul Paul | Executive | Award | 55,000 | $N/A | $0 | |
| Aug 6, 2019 | Azoy Alexander | Executive | Award | 70,000 | $N/A | $0 | |
| Aug 6, 2019 | K. Andrews Timothy | Executive | Award | 50,000 | $N/A | $0 | |
| Jul 2, 2019 | Frederick Beddingfield III | Executive | Payment | 17,063 | $0.76 | $13.0K | |
| Jul 2, 2019 | Azoy Alexander | Executive | Payment | 1,552 | $0.76 | $1.2K | |
| Jul 2, 2019 | F. Lizzul Paul | Executive | Payment | 4,095 | $0.76 | $3.1K | |
| Jul 2, 2019 | K. Andrews Timothy | Executive | Payment | 4,095 | $0.76 | $3.1K | |
| Jul 2, 2019 | Stroehmann Diane | Executive | Payment | 4,095 | $0.76 | $3.1K | |
| Apr 1, 2019 | Azoy Alexander | Executive | Award | 20,000 | $N/A | $0 | |
| Feb 22, 2019 | Frederick Beddingfield III | Executive | Purchase | 40,000 | $2.50 | $100.0K | |
| Feb 22, 2019 | R. Leonard Keith | Executive | Purchase | 100,000 | $2.50 | $250.0K | |
| Feb 22, 2019 | J. More Robert | Executive | Purchase | 100,000 | $2.50 | $250.0K | |
| Feb 22, 2019 | Burow Kristina | Executive | Purchase | 150,000 | $2.50 | $375.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 19 | $17.8M | 91.3% |
Sale(S) | 16 | $1.7M | 8.6% |
Payment(F) | 6 | $24.0K | 0.1% |
Award(A) | 10 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Conversion(C) | 20 | $0 | 0.0% |
Insiders at Sienna Biopharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 17 insiders making 72 transactions totaling $17.8M in purchases versus $1.7M in sales, the net buying activity of $16.1M signals strong executive confidence. Kristina Burow (Executive) leads the buying activity with $5.4M in transactions across all time.